Effects of enteral nutrition with parenteral glutamine supplementation on the immunological function in septic rats

British Journal of Nutrition

Volumn 113, Issue 11, 2015, Pages 1712-1722

  Fan, Jun ^a   Wu, Lidong ^a   Li, Guoping ^a   Tao, Shaoyu ^a   Sheng, Zhiyong ^a   Meng, Qingyan ^b   Li, Fengxin ^a   Yu, Lijuan ^a   Li, Li ^a  

^a NANCHANG UNIVERSITY   (China)

^b Northern Hospital   (China)

Author keywords

Cytokines; Enteral nutrition; Glutamine; Immunity; Sepsis

Indexed keywords

ALANYLGLUTAMINE; GLUTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CARBOHYDRATE DIET; FAT INTAKE; IMMUNOGLOBULIN; PROTEIN INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CD4 CD8 RATIO; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; ENTERIC FEEDING; FOOD COMPOSITION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; NONHUMAN; PARENTERAL NUTRITION; PHAGOCYTOSIS; PROTEIN BLOOD LEVEL; RAT; SPLEEN; SUPPLEMENTATION; SURVIVAL RATE; T LYMPHOCYTE; THYMUS; ADMINISTRATION AND DOSAGE; ANIMAL; APOPTOSIS; BLOOD; CALORIC INTAKE; CARBOHYDRATE DIET; CECUM; DIET SUPPLEMENTATION; DRUG EFFECTS; FAT INTAKE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PROCEDURES; PROTEIN INTAKE; SEPSIS; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; CECUM; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; DIETARY SUPPLEMENTS; ENERGY INTAKE; ENTERAL NUTRITION; GLUTAMINE; IMMUNOGLOBULINS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LYMPHOCYTE COUNT; MALE; NEUTROPHILS; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930907223     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515001099     Document Type: Article

References (56)

1. Boomer JS, Green JM & Hotchkiss RS (2014) The changing immune system in sepsis: is individualized immunomodulatory therapy the answer Virulence 5, 45-56.
2. Muenzer JT, Davis CG & Chang K (2010) Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 78, 1582-1592.
3. Hutchins NA, Unsinger J & Hotchkiss RS (2014) The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med 20, 224-233.
4. Remick DG (2007) Pathophysiology of sepsis. Am J Pathol 170, 1435-1444.
5. Santora R & Kozar RA (2010) Molecular mechanisms of pharmaconutrients. J Surg Res 161, 288-294.
6. Anbar R (2013) Enteral nutrition. World Rev Nutr Diet 105, 50-58.
7. Elke G, Wang M, Weiler N, et al. (2014) Close to recommended caloric and protein intake by enteral nutrition is associated with better clinical outcome of critically ill septic patients: secondary analysis of a large international nutrition database. Crit Care 18, R29.
8. Braga M, Wischmeyer PE, Drover J, et al. (2013) Clinical evidence for pharmaconutrition in major elective surgery. JPEN J Parenter Enteral Nutr 37, 66S-72S.
9. Lacey JM & Wilmore DW (1990) Is glutamine a conditionally essential amino acid Nutr Rev 48, 297-309.
10. Cruzat VF, Pantaleaõ LC, Donato J Jr, et al. (2014) Oral supplementations with free and dipeptide forms of L-glutamine in endotoxemic mice: effects on muscle glutamine-glutathione axis and heat shock proteins. J Nutr Biochem 25, 345-352.
11. Hou YC, Chiu WC, Yeh CL, et al. (2012) Glutamine modulates lipopolysaccharide-induced activation of NF-kB via the Akt/mTOR pathway in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 302, L174-L183.
12. Lee CH, Kim HK, Jeong JS, et al. (2015) Mechanism of glutamine inhibition of cytosolic phospholipase A2 (cPLA2): evidence of physical interaction between glutamine-induced MAPK phosphatase-1 and cPLA2. Clin Exp Immunol (Epublication ahead of print version).
13. Cruzat VF, Bittencourt A, Scomazzon SP, et al. (2014) Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia. Nutrition 30, 602-611.
14. Hou YC, Pai MH, Liu JJ, et al. (2013) Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells. J Nutr Biochem 24, 1555-1563.
15. Kwon WY, Suh GJ, Kim KS, et al. (2010) Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr 103, 890-898.
16. Hu YM, Pai MH, Yeh CL, et al. (2012) Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. Am J Physiol Renal Physiol 302, F150-F158.
17. Zhou W, Li W, Zheng XH, et al. (2014) Glutamine downregulates TLR-2 and TLR-4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis. J Pediatr Surg 49, 1057-1063.
18. Joo E, Yamane S, Hamasaki A, et al. (2013) Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice. Nutrition 29, 549-555.
19. Fan J, Meng QY, Guo GH, et al. (2009) Effects of enteral nutrition supplemented with glutamine on intestinal mucosal immunity in burned mice. Nutrition 25, 233-239.
20. Fan J, Meng QY, Guo GH, et al. (2010) Effects of glutamine added to enteral nutrition on Peyer's patch apoptosis in severely burned mice. Burns 36, 409-417.
21. Hu YM, Yeh CL, Pai MH, et al. (2014) Glutamine administration modulates lung gd T lymphocyte expression in mice with polymicrobial sepsis. Shock 41, 115-122.
22. Tung JN, Lee WY, Pai MH, et al. (2013) Glutamine modulates CD8aa(\+) TCRab(\+) intestinal intraepithelial lymphocyte expression in mice with polymicrobial sepsis. Nutrition 29, 911-917.
23. Lee WY, Hu YM, Ko TL, et al. (2012) Glutamine modulates sepsis-induced changes to intestinal intraepithelial gd T lymphocyte expression in mice. Shock 38, 288-293.
24. Cavalcante AA, Campelo MW, de Vasconcelos MP, et al. (2012) Enteral nutrition supplemented with L-glutamine in patients with systemic inflammatory response syndrome due to pulmonary infection. Nutrition 28, 397-402.
25. Peng X, Yan H, You Z, et al. (2006) Glutamine granulesupplemented enteral nutrition maintains immunological function in severely burned patients. Burns 32, 589-593.
26. Bollhalder L, Pfeil AM, Tomonaga Y, et al. (2013) A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 32, 213-223.
27. Heyland D, Muscedere J, Wischmeyer PE, et al. (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368, 1489-1497.
28. Wischmeyer PE, Dhaliwal R, McCall M, et al. (2014) Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care 18, R76.
29. Teerlink T, Hennekes MW, Van Leeuwen PA, et al. (1993) Rapid determination of glutamine in biological samples by high-performance liquid chromatography. Clin Chim Acta 218, 159-168.
30. Woodside KJ, Spies M, Wu XW, et al. (2003) Decreased lymphocyte apoptosis by anti-tumor necrosis factor antibody in PPs after severe burn. Shock 20, 70-73.
31. Medina E (2010) Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP). Methods Mol Biol 602, 411-415.
32. Andrews PJ, Avenell A & Noble DW (2011) Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 342, d1542.
33. Le Tulzo Y, Pangault C, Gacouin A, et al. (2002) Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18, 487-494.
34. Hotchkiss RS & Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348, 138-150.
35. Felmet KA, Hall MW, Clark RS, et al. (2005) Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174, 3765-3772.
36. Drewry AM, Samra N, Skrupky LP, et al. (2014) Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42, 383-391.
37. Furukawa S, Saito H, Inoue T, et al. (2000) Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients in vitro. Nutrition 16, 323-329.
38. Zou L, Feng Y, Zhang M, et al. (2011) Nonhematopoietic Tolllike receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis. Shock 36, 370-380.
39. Manhart N, Vierlinger K, Spittler A, et al. (2001) Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann Surg 234, 92-97.
40. Briassoulis G, Venkataraman S & Thompson A (2010) Cytokines and metabolic patterns in pediatric patients with critical illness. Clin Dev Immunol 2010, 354047.
41. Träger K, DeBacker D & Radermacher P (2003) Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 9, 271-278.
42. Boelens PG, Nijveldt RJ, Houdijk AP, et al. (2001) Glutamine alimentation in catabolic state. J Nutr 131, Suppl. 9, 2569S-2577S.
43. Karinch AM, Pan M, Lin CM, et al. (2001) Glutamine metabolism in sepsis and infection. J Nutr 131, Suppl. 9, 2535S-2538S.
44. Holecek M & Sispera L (2014) Glutamine deficiency in extracellular fluid exerts adverse effects on protein and amino acid metabolism in skeletal muscle of healthy, laparotomized, and septic rats. Amino Acids 46, 1377-1384.
45. Roth E (2008) Nonnutritive effects of glutamine. J Nutr 138, 2025S-2031S.
46. Hotchkiss RS, Tinsley KW, Swanson PE, et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4\+ T lymphocytes in humans. J Immunol 166, 6952-6963.
47. Wesche DE, Lomas-Neira JL, Perl M, et al. (2005) Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 78, 325-337.
48. Luan YY, Yao YM, Xiao XZ, et al. (2015) Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res 35, 17-22.
49. Yin HY, Wei JR, Zhang R, et al. (2014) Effect of glutamine on caspase-3 mRNA and protein expression in the myocardium of rats with sepsis. Am J Med Sci 348, 315-318.
50. de Oliveira GP, Silva JD, de Araújo CC, et al. (2014) Intravenous glutamine administration reduces lung and distal organ injury in malnourished rats with sepsis. Shock 41, 222-232.
51. Kim YS, Jung MH, Choi MY, et al. (2009) Glutamine attenuates tubular cell apoptosis in acute kidney injury via inhibition of the c-Jun N-terminal kinase phosphorylation of 14-3-3. Crit Care Med 37, 2033-2044.
52. Uehara K, Takahashi T, Fujii H, et al. (2005) The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med 33, 381-390.
53. Margaritis VG, Filos KS, Michalaki MA, et al. (2005) Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg 29, 1329-1334.
54. Kessel A, Toubi E, Pavlotzky E, et al. (2008) Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. Clin Exp Immunol 151, 341-347.
55. Singleton KD, Beckey VE & Wischmeyer PE (2005) Glutamine prevents activation of NF-kB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24, 583-589.
56. Singleton KD, Serkova N, Beckey VE, et al. (2005) Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 33, 1206-1213.